PELOBiotech Distributes now ReachBio’s full product line Exclusive in Europe

PELOBiotech Distributes now ReachBio’s full product line Exclusive in Europe

PELOBiotech GmbH (Planegg, Germany) has signed an agreement with #ReachBio Research Labs (Seattle, WA, USA) giving PELOBiotech exclusive distribution rights to ReachBio’s full product line for the life science research market within Europe.

ReachBio provides research products and contract services (#cellPrism® drug development platform) for applications in basic life science research, drug research & development, toxicology and immunology. The company’s main product lines consist of cryopreserved normal human #primary cells derived from peripheral blood (including PBMCs), cord blood, bone marrow, as well as ColonyGEL™ methylcellulose-based media for hematopoietic colony-forming cell (#CFC) assays.

Read more here.